Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Quest Diagnostics (DGX)
NYSE:DGX
Holding DGX?
Track your performance easily
Quest Diagnostics (DGX) Ownership Overview
0.41% Insiders
27.88% Mutual Funds
15.74% Other Institutional Investors
27.10% ETFs
28.87% Public Companies and
Individual Investors
The ownership structure of Quest Diagnostics (DGX) stock is a mix of institutional, retail, and individual investors. Approximately 70.72% of the company’s stock is owned by Institutional Investors, 0.41% is owned by Insiders, and 28.87% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 30, 2024 | Karthik Kuppusamy Svp, Clinical Solutions | xxxxxxxxxxxxx | $278515 |
| Sep 03, 2024 | Michael Prevoznik Svp & Gc | xxxxxxxxxxxxx | $5044428 |
| Jul 26, 2024 | Mark E Delaney Svp & Cco | xxxxxxxxxxxxx | $60094 |
| Feb 23, 2024 | Vicky Gregg Director | xxxxxxxxxxxxx | $316575 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $289696 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $309413 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $768332 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1350675 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,649,086 | Institution | 11.33% | 2,054,717,530 | |
| 10,533,355 | Institution | 9.44% | 1,711,038,186 | |
| 6,649,522 | Institution | 5.96% | 1,080,148,354 | |
| 4,151,687 | Institution | 3.72% | 674,400,036 | |
| 2,600,683 | Institution | 2.33% | 422,454,947 | |
| 2,399,103 | Institution | 2.15% | 389,710,291 | |
| 1,802,042 | Institution | 1.61% | 292,723,702 | |
| 1,673,214 | Institution | 1.50% | 271,796,882 | |
| 1,592,699 | Institution | 1.43% | 258,718,026 | |
| 1,480,753 | Institution | 1.33% | 240,533,517 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,533,355 | Institution | 9.44% | 1,711,038,186 | |
| 2,600,683 | Institution | 2.33% | 422,454,947 | |
| 1,802,042 | Institution | 1.61% | 292,723,702 | |
| 1,673,214 | Institution | 1.50% | 271,796,882 | |
| 1,592,699 | Institution | 1.43% | 258,718,026 | |
| 853,909 | Institution | 0.77% | 138,708,978 | |
| 790,702 | Institution | 0.71% | 128,441,633 | |
| 734,630 | Institution | 0.66% | 119,333,297 | |
| 712,869 | Institution | 0.64% | 115,798,440 | |
| 606,312 | Institution | 0.54% | 98,489,321 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,501,401 | Institution | 3.14% | 542,121,917 | |
| 2,949,561 | Institution | 2.64% | 456,680,530 | |
| 2,361,766 | Institution | 2.12% | 365,672,230 | |
| 1,371,336 | Institution | 1.23% | 224,336,856 | |
| 1,371,336 | Institution | 1.23% | 224,336,856 | |
| 1,249,007 | Institution | 1.12% | 202,888,697 | |
| 945,013 | Institution | 0.85% | 146,316,363 | |
| 880,035 | Institution | 0.79% | 143,964,926 | |
| 815,990 | Institution | 0.73% | 133,487,804 | |
| 766,671 | Institution | 0.69% | 118,703,671 |
FAQ
Who Owns Quest Diagnostics (DGX)?
According to the latest TipRanks data, approximately 15.74% of the company's stock is held by institutional investors, 0.41% is held by insiders, and 28.87% is held by retail investors.
What percentage of Quest Diagnostics (DGX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 15.74% of Quest Diagnostics (DGX) stock is held by institutional investors.
What percentage of Quest Diagnostics (DGX) stock is held by retail investors?
According to the latest TipRanks data, approximately 28.87% of Quest Diagnostics (DGX) stock is held by retail investors.
Who owns the most shares of Quest Diagnostics (DGX)?
Vanguard owns the most shares of Quest Diagnostics (DGX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.